These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7360488)

  • 41. [Resistance testing and chemotherapy results of bronchial tumours (author's transl)].
    Volm M; Wayss K; Mattern J; Kleckow M; Vogt-Moykopf I
    Dtsch Med Wochenschr; 1978 Aug; 103(32):1266-70. PubMed ID: 668581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
    Kolfschoten GM; Pinedo HM; Scheffer PG; Schlüper HM; Erkelens CA; Boven E
    Gynecol Oncol; 2000 Mar; 76(3):362-8. PubMed ID: 10684711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel dye exclusion method for testing in vitro chemosensitivity of human tumors.
    Weisenthal LM; Marsden JA; Dill PL; Macaluso CK
    Cancer Res; 1983 Feb; 43(2):749-57. PubMed ID: 6184155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chemotherapy of prostatic cancer].
    Portnoĭ AS
    Vopr Onkol; 1985; 31(9):3-12. PubMed ID: 2931901
    [No Abstract]   [Full Text] [Related]  

  • 45. [Antineoplastic polychemotherapy in thoracic pathology].
    Mannes P; Derriks R; Moens R; Heynen E
    Poumon Coeur; 1968; 24(1):83-91. PubMed ID: 4968018
    [No Abstract]   [Full Text] [Related]  

  • 46. Expression of BAF57 in ovarian cancer cells and drug sensitivity.
    Yamaguchi T; Kurita T; Nishio K; Tsukada J; Hachisuga T; Morimoto Y; Iwai Y; Izumi H
    Cancer Sci; 2015 Apr; 106(4):359-66. PubMed ID: 25611552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Burkitt's lymphoma and acute leukemias].
    Ravina A
    Presse Med (1893); 1969 Feb; 77(7):245-6. PubMed ID: 4895891
    [No Abstract]   [Full Text] [Related]  

  • 48. The use of human cancer cell lines as a primary screening system for antineoplastic compounds.
    Finlay GJ; Baguley BC
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):947-54. PubMed ID: 6540194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guide to the use of cancer chemotherapeutic agents.
    Bergevin PR; Tormey DC; Blom J
    Mod Treat; 1972 May; 9(2):185-273. PubMed ID: 4117324
    [No Abstract]   [Full Text] [Related]  

  • 50. Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.
    De Palo GM; De Lena M; Bonadonna G
    Cancer Treat Rep; 1977; 61(3):355-7. PubMed ID: 326402
    [No Abstract]   [Full Text] [Related]  

  • 51. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Principles of the effect of cytostatics].
    Siering VH; Abendroth K
    Z Gesamte Inn Med; 1974 Nov; 29(21):866-70. PubMed ID: 4142666
    [No Abstract]   [Full Text] [Related]  

  • 53. Preclinical screening for drugs effective against 5-fluorouracil-resistant cells with a murine L5178Y cell line in vitro.
    Hill BT
    J Natl Cancer Inst; 1983 Aug; 71(2):335-40. PubMed ID: 6576190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Editorial: Drug targets in cancer chemotherapy.
    Br Med J; 1974 Dec; 4(5947):730-1. PubMed ID: 4140747
    [No Abstract]   [Full Text] [Related]  

  • 55. [Chemotherapic management of genitomammary tumors].
    Sarría JA; Irigoyen ML; Cismondi B
    Rev Fac Cien Med Univ Nac Cordoba; 1981; 39(1-4):3-16. PubMed ID: 6897122
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparison of the results of single-drug and combination chemotherapy of advanced ovarian cancer after 1 year].
    Sablińska B; Cześnin K; Ploch E
    Ginekol Pol; 1979 Jun; 50(6):501-5. PubMed ID: 478338
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical pharmacology of anticancer drugs.
    Chabner BA; Myers CE; Oliverio VT
    Semin Oncol; 1977 Jun; 4(2):165-91. PubMed ID: 69319
    [No Abstract]   [Full Text] [Related]  

  • 58. Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy.
    Berry RJ; Laing AH; Wells J
    Br J Cancer; 1975 Feb; 31(2):218-27. PubMed ID: 809049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotherapeutic remissions in Wistar Furth rat acute myelogenous leukemia: a model for human AML.
    Greenberger JS; Bocaccino CA; Szot SJ; Moloney WC
    Acta Haematol; 1977 Mar; 57(4):233-41. PubMed ID: 66830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of intralesional in vivo chemotherapy of line 10 hepatoma with in vitro drug sensitivity.
    Osman FA; Bier J; Bier H; Siegel T; Maurer HR; Ohanian S
    Int J Cell Cloning; 1983 Jun; 1(2):118-27. PubMed ID: 6199438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.